Pharmesis International Ltd. (SG:BFK) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Pharmesis International Ltd., a Singapore-based company specializing in health and pharmaceutical products, has announced the launch of its FDA-certified Infinity Wolfberry series through its subsidiary, Chengdu Kinna Pharmaceutical Co., Ltd. These products, which include various wolfberry-based items, are part of the company’s strategy to target overseas markets and promote a healthy lifestyle. The Infinity Wolfberry series garnered significant interest at the Western Health Pharmaceutical Ingredients and Health Products Exhibition in California, connecting Kinna with over a hundred potential customers.
For further insights into SG:BFK stock, check out TipRanks’ Stock Analysis page.